SN Oncology Webinar Series

SN Oncology Webinar Series

Springer Nature

SN Oncology Portfolio

These webinars bring together international experts to discuss ongoing developments on hot topics in cancer research.

Speakers
Community
Prof. Haidong Dong
Prof. Adrian Harris
Prof. Jan Paul Medema
Prof. Yi-Long Wu
Dr. Alexia-Ileana Zaromytidou
Prof. Klaus Pantel
Prof. Dennis Lo
Dr. Myron G. Best
+74
Dr Ben Kaube
Prof. Dr. Torsten Tonn MD, PHD
Prof. Jianhua Yu
Professor Subramaniam Malarkannan Ph.D.
Dr. Andrew Preston
Prof. Peter Vincent
Dr. Marziyeh Nazari
Dr Paraskevi Mallini
+1274
SN Oncology Portfolio
SN Oncology Portfolio
Springer Nature Cancer Community

Seminars in preparation

Selection of Donors for Hematopoietic Cell Transplantation: Donor age is becoming more and more important
In preparation
TU Dresden
DKMS Foundation

Selection of Donors for Hematopoietic Cell Transplantation: Donor age is becoming more and more important

Professor, DKMS Group
agenT-797: Allogeneic iNKT Cell Therapy for the Treatment of Cancer - Complete Clinical Response in a R/R Germ Cell Tumor
In preparation

agenT-797: Allogeneic iNKT Cell Therapy for the Treatment of Cancer - Complete Clinical Response in a R/R Germ Cell Tumor

Marco Purbhoo, MiNK Therapeutics
Multicellular Tumor-Stromal Interactions Recapitulate Aspects of Therapeutic Response and Human Oncogenic Signaling in a 3D Disease Model for H3K27M-altered DIPG
In preparation
Children's Hospital of Los Angeles

Multicellular Tumor-Stromal Interactions Recapitulate Aspects of Therapeutic Response and Human Oncogenic Signaling in a 3D Disease Model for H3K27M-altered DIPG

Dr Meenakshi Upreti, Children's Hospital of Los Angeles
Salvage therapy with allogeneic invariant natural killer cells in a heavily pre-treated germ cell tumor
In preparation
Sarah Cannon Research Institute

Salvage therapy with allogeneic invariant natural killer cells in a heavily pre-treated germ cell tumor

Benjamin Garmezy, Sarah Cannon Research Institute
A molecular signature predicts hematologic evolution in polycythemia vera patients
In preparation
Centre Hospitalier Universitaire d'Angers

A molecular signature predicts hematologic evolution in polycythemia vera patients

Damien Luque Paz, Centre Hospitalier Universitaire d'Angers
Flow Cytometry based definition of Plasma Cell Leukemia
In preparation
Mayo Clinic

Flow Cytometry based definition of Plasma Cell Leukemia

Arwa Bohra, Mayo Clinic

Published seminars

NOTCH1 signaling is dysregulated by loss of the deubiquitinase USP28 with del(11q), uncovering USP28 inhibition as novel therapeutic target in CLL
Jun 30
German Cancer Research Center
University Hospital Ulm

NOTCH1 signaling is dysregulated by loss of the deubiquitinase USP28 with del(11q), uncovering USP28 inhibition as novel therapeutic target in CLL

Alena Ehrmann, German Cancer Research Center and University Hospital Ulm
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants
May 28
Northwestern University

Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants

Dr Godley, Northwestern University
Anti-T lymphocyte Globulin plus Posttransplant Cyclophosphamide 25 mg/kg versus Posttransplant Cyclophosphamide 50 mg/kg in Patients with Acute Leukemias
Apr 18

Anti-T lymphocyte Globulin plus Posttransplant Cyclophosphamide 25 mg/kg versus Posttransplant Cyclophosphamide 50 mg/kg in Patients with Acute Leukemias

Turgay Ulas, Ankara Oncology Hospital
Characterizing the tumor suppressor activity of FLCN in Birt-Hogg-Dubé syndrome cell models through transcriptomic and proteomic analysis
Apr 8
Cardiff University

Characterizing the tumor suppressor activity of FLCN in Birt-Hogg-Dubé syndrome cell models through transcriptomic and proteomic analysis

Andrew R. Tee, Cardiff University
Early Morbimortality in Autologous Hematopoietic Cell Transplantation Performed on Outpatient Basis in Patients with Autoimmune Diseases: Experience in 1700 Patients
Mar 19
Clínica Ruiz

Early Morbimortality in Autologous Hematopoietic Cell Transplantation Performed on Outpatient Basis in Patients with Autoimmune Diseases: Experience in 1700 Patients

Professor Guillermo J.- Ruiz-Argüelles, Clínica Ruiz
aGvHDtrackR and cGvHDtrackR: shiny applications for graft versus host disease management and clinical data collection
Jan 20
University of Milano-Bicocca
Azienda Ospedaliera San Gerardo

aGvHDtrackR and cGvHDtrackR: shiny applications for graft versus host disease management and clinical data collection

Dr Silvia Nucera, University of Milano-Bicocca and Azienda Ospedaliera San Gerardo
Radiation Reveal: Moving from research engagement to involvement
Dec 2024
King's College London

Radiation Reveal: Moving from research engagement to involvement

Samantha Terry, King's College London
Lisa Whittaker, King's College London
+1 speaker
A CADASIL NOTCH3 mutation leads to clonal hematopoiesis and expansion of Dnmt3a-R878H hematopoietic clones
Nov 2024
Queen Mary University of London

A CADASIL NOTCH3 mutation leads to clonal hematopoiesis and expansion of Dnmt3a-R878H hematopoietic clones

Miguel Ganuza, Queen Mary University of London
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial
Oct 2024
Assistance Publique – Hôpitaux de Paris
University of Western Australia

Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial

Catherine Thieblemont, Assistance Publique – Hôpitaux de Paris
Chan Y. Cheah, University of Western Australia and Sir Charles Gairdner Hospital